𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Global variations in cancer survival

✍ Scribed by R. Sankaranarayanan; R. Swaminathan; R. J. Black; for the Study Group on Cancer Survival in Developing Countries


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
337 KB
Volume
78
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Colon Cancer Survival in Finland
✍ G. Launoy; M. Gignoux; X. L. Coutour; Anssi Auvinen πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 152 KB πŸ‘ 2 views
Disparities in cancer diagnosis and surv
✍ Cathy J. Bradley; Charles W. Given; Caralee Roberts πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views
Ethnicity and variation in breast cancer
✍ Louise A. Brinton; Jacques Benichou; Marilie D. Gammon; Donna R. Brogan; Ralph C πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

A breast cancer case-control study in Atlanta and 5 counties of central New Jersey involving interviews with 960 white and 281 black cases younger than 54 years of age enabled assessment of reasons for the varying incidence rates among these 2 ethnic groups. Of interest was why rates of breast cance

Hla type and survival in lung cancer
✍ Gary B. Weiss; Lynn B. Nawrocki; Jerry C. Daniels πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

A significant positive association between antigens HLA Awl9 andlor HLA B5 and a disease-free survival time of one year for patients with lung cancer has been reported but not confirmed. We have HLAtyped 20 white patients with non-oat-cell bronchogenic carcinoma who have survived at least a year fro

Survival of women with breast cancer in
✍ Milena Sant; Riccardo Capocaccia; Arduino Verdecchia; Jacques EstΓ¨ve; Gemma Gatt πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 89 KB πŸ‘ 2 views

Breast cancer is the most frequent malignancy among women in developed countries. Prognosis is better than for other major cancers, and an improvement in survival has been reported for several populations in recent decades. Within the framework of EUROCARE, a population-based project concerned with